Trial Details
RECRUITINGBasic Information
| Clinical ID | c73 |
|---|---|
| Identifier | NCT07229950 |
| Trial Title | A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Adult Patients With Moderately to Severely Active Ulcerative Colitis |
| Interventions | DRUG: HRS-7085|DRUG: HRS-7085|DRUG: Placebo |
Participant Information
| Sponsor | Shandong Suncadia Medicine Co., Ltd. |
|---|---|
| City | Sichuan |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-10-17 |
|---|---|
| Primary Completion Date | 2026-12 |
| Completion Date | 2026-12 |